Form 4/A for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001213900-22-007951 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-02-15 | 2022-02-11 | ORMP | RAKIN KEVIN | Dir | G - Gift | $0.00 | -5,000 | 53.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | G | D | 5,000 | $0.00 | 53,004 | D | — | — | (F1) This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. (F2) This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rakin, which reported that 47,004 shares of common stock are beneficially owned by him following the reported transaction. Mr. Rakin beneficially owned 53,004 shares of common stock following the reported transaction. |